Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is VALACYCLOVIR HYDROCHLORIDE USP, with a corresponding US DMF Number 17943.
Remarkably, this DMF maintains an Active status since its submission on December 29, 2004, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 13, 2019, and payment made on August 09, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II